Venture Capital/Consumer, fintech, SaaS, Consumer technology
Kae Capital logo

Kae Capital

Pre-seed fund research profile

Kae Capital is a day-one India technology investor that has stayed close to commerce, finance, healthcare and enterprise technology. The manager’s model is early conviction followed by long-term engagement, with public outcomes from Porter, HealthKart, Zetwerk, Nazara and 1mg. This directory record bundles the manager's related fund series into one family view while retaining vehicle-level terms, portfolios, dates and sources below.

At a glance

Founded
2012
Footprint
Mumbai
Stage
Pre-seed / seed; Seed to Series A; multiple fund vintages bundled

Research profile

Read the manager in sequence.

Open a section to inspect the evidence. The first view starts with the investment point of view; the rest stays quiet until you need it.

Investment lens

Kae Capital uses a pre-seed / seed; seed to series a; multiple fund vintages bundled approach across Consumer, fintech, SaaS, Consumer technology.

Current evidence

Kae’s current 2025–2026 Fund I announcement and VCCircle coverage report the maiden vehicle’s realised outcome and named portfolio.

Bundled fund series

Related manager and vehicle records are shown here as one fund family. The original source trails and vehicle-level caveats remain preserved in the research record.

Kae Capital

Vintage / record year: 2012

Kae Capital Fund I

Vintage / record year: 2012

Kae Capital Fund II

Vintage / record year: 2015

Strategy

Pre-seed / seed; Seed to Series A; multiple fund vintages bundled

Sector focus

Consumer, fintech, SaaS, Consumer technology

AIF structure context

Indian venture capital and angel-fund strategies are commonly structured as Category I AIFs. Verify the specific vehicle and registration before investing.

Current signal

Kae’s current 2025–2026 Fund I announcement and VCCircle coverage report the maiden vehicle’s realised outcome and named portfolio.

Investor questions

Kae Capital research questions

What is Kae Capital's investment strategy?

Kae Capital is covered in Rupeia's venture capital research universe. The current public record describes the strategy as Pre-seed / seed; Seed to Series A; multiple fund vintages bundled, with a sector focus of Consumer, fintech, SaaS, Consumer technology. The profile should be read with the linked source trail and Typical route: Category I AIF context.

What portfolio evidence is available for Kae Capital?

The profile displays only company or asset names attributable to Kae Capital in the reviewed public sources: Porter, HealthKart, Zetwerk, Nazara, Fynd, Tata 1mg, Certa, Dailyround, Airwoot, Eventifier, Nazara Technologies, Snapmint. It does not represent a complete current portfolio unless the manager has published one.

What is known about Kae Capital's performance or track record?

Kae says Fund I delivered 3.6x DPI as of September 2023 and was fully exited in 2025; Porter returned more than twice Fund I’s capital and HealthKart matched the fund size in returns. These are manager-reported vintage outcomes, not a whole-platform net IRR. These signals are not a substitute for fund- and vintage-specific net performance, realised distributions and audited or administrator-supported reporting.

What are Kae Capital's fund size, fees and minimum investment?

Public fund size: Fund I was $25M; the manager says it manages more than $250M across three funds and has backed 90+ startups. Current Fund IV corpus is not independently confirmed in the reviewed record. Series-level sizing is retained below; aggregate family AUM is not inferred.. Public terms or access information: Pre-seed and seed technology investing, with first-institutional cheques and follow-on support. The public record does not consistently state current ticket size or ownership targets.. Current fees, minimum commitment and availability must be confirmed for the exact named vehicle in its fund documents.

Who is on Kae Capital's investment team?

The current source record names Sasha Mirchandani, Sunitha Viswanathan, Gaurav Chaturvedi, Abhishek Srivastava. Verify current roles, departures, attribution and key-person provisions before relying on the team history for a new commitment.

What risks should be reviewed before investing with Kae Capital?

Review stage concentration, follow-on reserves, company failure rates, dilution, exit timing and the gap between paper valuations and realised distributions. The current open diligence point is: Current fund vehicle, terms and post-2023 deployment are not fully disclosed. Vehicle-level differences remain identified in the bundled series records..

What is the latest public update on Kae Capital?

2026-10-20: Kae’s current 2025–2026 Fund I announcement and VCCircle coverage report the maiden vehicle’s realised outcome and named portfolio.

Next step

Need this manager reviewed against your mandate?

Share the allocation question, ticket size, liquidity constraints and existing exposure. Rupeia can determine whether this profile needs a deeper decision-support brief.

Request independent diligence →